Amir Nashat Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Amir Nashat.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Amir Nashat. Amir Nashat is a Director in aTYR PHARMA INC ($LIFE) and a Director in BIND Therapeutics, Inc ($BIND) and a Director in FATE THERAPEUTICS INC ($FATE) and a Director in SELECTA BIOSCIENCES INC ($SELB) and a Director in Receptos, Inc. ($RCPT) and a Director in Syros Pharmaceuticals, Inc. ($SYRS) and a Director in Metacrine, Inc. ($MTCR) and a Director in Morphic Holding, Inc. ($MORF) and a Director in Scholar Rock Holding Corp ($SRRK).

Address: 10835 ROAD TO THE CURE, SUITE 205 SAN DIEGO 92121 CA

Companies in which Amir Nashat is an Insider

aTYR PHARMA INC

Trading Symbol: LIFE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Amir Nashat: Director
Holdings: 17,638 shares
Current Value: $59,969
Latest Transaction: May 17 2018
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

DNIB UNWIND, INC.

Trading Symbol: BIND
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amir Nashat: Director
Holdings: 0 shares
Latest Transaction: Jun 10 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

FATE THERAPEUTICS INC

Trading Symbol: FATE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Amir Nashat: Director
Holdings: 1,129,554 shares
Current Value: $3,162,751
Latest Transaction: Aug 02 2019
$FATE Market Capitalization: $95.27M
$FATE Previous Close: $2.80

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Metacrine, Inc.

Trading Symbol: MTCR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amir Nashat: Director
Holdings: 214,962 shares
Latest Transaction: Sep 22 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Morphic Holding, Inc.

Trading Symbol: MORF
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amir Nashat: Director
Holdings: 473,276 shares
Latest Transaction: Jun 17 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Receptos, Inc.

Trading Symbol: RCPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amir Nashat: Director
Holdings: 1,186,940 shares
Latest Transaction: Jul 19 2013

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Scholar Rock Holding Corp

Trading Symbol: SRRK
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Amir Nashat: Director
Holdings: 330,948 shares
Latest Transaction: Jun 18 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SELECTA BIOSCIENCES INC

Trading Symbol: SELB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amir Nashat: Director
Holdings: 52,156 shares
Latest Transaction: Jun 18 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Syros Pharmaceuticals, Inc.

Trading Symbol: SYRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amir Nashat: Director
Holdings: 1,164,486 shares
Current Value: $12,716,187
Latest Transaction: Jun 11 2020
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Amir Nashat

Sentiment: All, LIFE, BIND, FATE, MTCR, MORF, RCPT, SRRK, SELB, SYRS

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 17 2021MORFMorphic Holding, I ...Nashat AmirDirectorOption ExerciseA64.7912,000777,48012,000
Sep 22 2020MTCRMetacrine, Inc.Nashat AmirDirectorOption ExerciseC0.0015,11800
Sep 22 2020MTCRMetacrine, Inc.Nashat AmirDirectorOption ExerciseC0.00216,10600
Sep 22 2020MTCRMetacrine, Inc.Nashat AmirDirectorOption ExerciseC0.0020,58500
Sep 22 2020MTCRMetacrine, Inc.Nashat AmirDirectorOption ExerciseC0.00451,66600
Sep 22 2020MTCRMetacrine, Inc.Nashat AmirDirectorOption ExerciseC0.00128,20100
Sep 22 2020MTCRMetacrine, Inc.Nashat AmirDirectorOption ExerciseC0.001,832,58200

View all Amir Nashat insider transactions.